Cargando…

Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram

BACKGROUND: Owing to the scarcity of upper urinary tract urothelial carcinoma (UUT-UC) it is often necessary for investigators to pool data. A patient-specific survival nomogram based on such data is needed to predict cancer-specific survival (CSS) post nephroureterectomy (NU). Herein, we propose an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yates, D R, Hupertan, V, Colin, P, Ouzzane, A, Descazeaud, A, Long, J A, Pignot, G, Crouzet, S, Rozet, F, Neuzillet, Y, Soulie, M, Bodin, T, Valeri, A, Cussenot, O, Rouprêt, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304431/
https://www.ncbi.nlm.nih.gov/pubmed/22374463
http://dx.doi.org/10.1038/bjc.2012.64
_version_ 1782226902380969984
author Yates, D R
Hupertan, V
Colin, P
Ouzzane, A
Descazeaud, A
Long, J A
Pignot, G
Crouzet, S
Rozet, F
Neuzillet, Y
Soulie, M
Bodin, T
Valeri, A
Cussenot, O
Rouprêt, M
author_facet Yates, D R
Hupertan, V
Colin, P
Ouzzane, A
Descazeaud, A
Long, J A
Pignot, G
Crouzet, S
Rozet, F
Neuzillet, Y
Soulie, M
Bodin, T
Valeri, A
Cussenot, O
Rouprêt, M
author_sort Yates, D R
collection PubMed
description BACKGROUND: Owing to the scarcity of upper urinary tract urothelial carcinoma (UUT-UC) it is often necessary for investigators to pool data. A patient-specific survival nomogram based on such data is needed to predict cancer-specific survival (CSS) post nephroureterectomy (NU). Herein, we propose and validate a nomogram to predict CSS post NU. PATIENTS AND METHODS: Twenty-one French institutions contributed data on 1120 patients treated with NU for UUT-UC. A total of 667 had full data for nomogram development. Study population was divided into the nomogram development cohort (397) and external validation cohort (270). Cox proportional hazards regression models were used for univariate and multivariate analyses and to build a nomogram. A reduced model selection was performed using a backward step-down selection process, and Harrell's concordance index (c-index) was used for quantifying the nomogram accuracy. Internal validation was performed by bootstrapping and the reduced nomogram model was calibrated. RESULTS: Of the 397 patients in the nomogram development cohort, 91 (22.9%) died during follow-up, of which 66 (72.5%) died as a consequence of UUT-UC. The actuarial CSS probability at 5 years was 0.76 (95% CI, 71.62-80.94). On multivariate analysis, T stage (P<0.0001), N status (P=0.014), grade (P=0.026), age (P=0.005) and location (P=0.022) were associated with CSS. The reduced nomogram model had an accuracy of 0.78. We propose a nomogram to predict 3 and 5-year CSS post NU for UUT-UC. CONCLUSION: We have devised and validated an accurate nomogram (78%), superior to any single clinical variable or current model, for predicting 5-year CSS post NU for UUT-UC.
format Online
Article
Text
id pubmed-3304431
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-33044312013-03-13 Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram Yates, D R Hupertan, V Colin, P Ouzzane, A Descazeaud, A Long, J A Pignot, G Crouzet, S Rozet, F Neuzillet, Y Soulie, M Bodin, T Valeri, A Cussenot, O Rouprêt, M Br J Cancer Clinical Study BACKGROUND: Owing to the scarcity of upper urinary tract urothelial carcinoma (UUT-UC) it is often necessary for investigators to pool data. A patient-specific survival nomogram based on such data is needed to predict cancer-specific survival (CSS) post nephroureterectomy (NU). Herein, we propose and validate a nomogram to predict CSS post NU. PATIENTS AND METHODS: Twenty-one French institutions contributed data on 1120 patients treated with NU for UUT-UC. A total of 667 had full data for nomogram development. Study population was divided into the nomogram development cohort (397) and external validation cohort (270). Cox proportional hazards regression models were used for univariate and multivariate analyses and to build a nomogram. A reduced model selection was performed using a backward step-down selection process, and Harrell's concordance index (c-index) was used for quantifying the nomogram accuracy. Internal validation was performed by bootstrapping and the reduced nomogram model was calibrated. RESULTS: Of the 397 patients in the nomogram development cohort, 91 (22.9%) died during follow-up, of which 66 (72.5%) died as a consequence of UUT-UC. The actuarial CSS probability at 5 years was 0.76 (95% CI, 71.62-80.94). On multivariate analysis, T stage (P<0.0001), N status (P=0.014), grade (P=0.026), age (P=0.005) and location (P=0.022) were associated with CSS. The reduced nomogram model had an accuracy of 0.78. We propose a nomogram to predict 3 and 5-year CSS post NU for UUT-UC. CONCLUSION: We have devised and validated an accurate nomogram (78%), superior to any single clinical variable or current model, for predicting 5-year CSS post NU for UUT-UC. Nature Publishing Group 2012-03-13 2012-02-28 /pmc/articles/PMC3304431/ /pubmed/22374463 http://dx.doi.org/10.1038/bjc.2012.64 Text en Copyright © 2012 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Yates, D R
Hupertan, V
Colin, P
Ouzzane, A
Descazeaud, A
Long, J A
Pignot, G
Crouzet, S
Rozet, F
Neuzillet, Y
Soulie, M
Bodin, T
Valeri, A
Cussenot, O
Rouprêt, M
Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
title Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
title_full Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
title_fullStr Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
title_full_unstemmed Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
title_short Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
title_sort cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304431/
https://www.ncbi.nlm.nih.gov/pubmed/22374463
http://dx.doi.org/10.1038/bjc.2012.64
work_keys_str_mv AT yatesdr cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT hupertanv cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT colinp cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT ouzzanea cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT descazeauda cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT longja cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT pignotg cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT crouzets cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT rozetf cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT neuzillety cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT souliem cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT bodint cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT valeria cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT cussenoto cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram
AT roupretm cancerspecificsurvivalafterradicalnephroureterectomyforupperurinarytracturothelialcarcinomaproposalandmultiinstitutionalvalidationofapostoperativenomogram